| Dr Spencer Elton Romine, MD | |
|
200 Clint Hill Blvd, Paducah, KY 42001-6768 | |
| (270) 442-9461 | |
| Not Available |
| Full Name | Dr Spencer Elton Romine |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 18 Years |
| Location | 200 Clint Hill Blvd, Paducah, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659535409 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 45405 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health - Home Care, Paducah | Paducah, KY | Home health agency |
| Baptist Health Paducah | Paducah, KY | Hospital |
| Lourdes Hospital | Paducah, KY | Hospital |
| Massac Memorial Hospital | Metropolis, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Institute Of Western Kentucky Pllc | 6204226061 | 29 |
| Health Facilities Rehab Services Inc | 3476679226 | 101 |
| Orthopaedic Institute Of Western Kentucky Pllc | 6204226061 | 29 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed.
In early October, an executive at one of the nation's largest physician-practice management firms handed her bosses the equivalent of a live grenade — a 20-page report that blew up the company and shook the world of managed care for poor patients across California.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 3 days ago
| Entity Name | Baptist Health Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922401611 PECOS PAC ID: 5597867184 Enrollment ID: O20150219000942 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed.
In early October, an executive at one of the nation's largest physician-practice management firms handed her bosses the equivalent of a live grenade — a 20-page report that blew up the company and shook the world of managed care for poor patients across California.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 3 days ago
| Entity Name | Mercy Health Physicians Kentucky Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700408093 PECOS PAC ID: 1456777069 Enrollment ID: O20200813001096 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed.
In early October, an executive at one of the nation's largest physician-practice management firms handed her bosses the equivalent of a live grenade — a 20-page report that blew up the company and shook the world of managed care for poor patients across California.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 3 days ago
| Entity Name | Baptist Health Deaconess Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437730942 PECOS PAC ID: 6103220330 Enrollment ID: O20210810000993 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed.
In early October, an executive at one of the nation's largest physician-practice management firms handed her bosses the equivalent of a live grenade — a 20-page report that blew up the company and shook the world of managed care for poor patients across California.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 3 days ago
| Entity Name | Orthopaedic Institute Of Western Kentucky Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497425177 PECOS PAC ID: 6204226061 Enrollment ID: O20211209001637 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed.
In early October, an executive at one of the nation's largest physician-practice management firms handed her bosses the equivalent of a live grenade — a 20-page report that blew up the company and shook the world of managed care for poor patients across California.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Spencer Elton Romine, MD 200 Clint Hill Blvd, Paducah, KY 42001-6768 Ph: (270) 442-9461 | Dr Spencer Elton Romine, MD 200 Clint Hill Blvd, Paducah, KY 42001-6768 Ph: (270) 442-9461 |
News Archive
Today the scientific journal Neuron published results on the Roche-designed Brain Shuttle technology that efficiently transfers investigational antibodies from the blood through the blood-brain barrier (BBB) into the brain in preclinical models.
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.
Pharmaceutical companies, hospitals, advocacy groups and others with a stake in health reform continue to lobby in hopes of winning concessions in the overhaul, or at least surviving the changes unscathed.
In early October, an executive at one of the nation's largest physician-practice management firms handed her bosses the equivalent of a live grenade — a 20-page report that blew up the company and shook the world of managed care for poor patients across California.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 3 days ago
Brian S Kern, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Clint Hill Blvd, Paducah, KY 42001 Phone: 270-442-9461 Fax: 270-441-0079 | |
Ryan Tyler Beck, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Clint Hill Blvd, Paducah, KY 42001 Phone: 270-442-9461 Fax: 270-441-0079 | |
Ted H Jefferson, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Kentucky Ave, Dob#3 Suite 602, Paducah, KY 42003 Phone: 270-442-2449 Fax: 270-442-6628 | |
Dr. William J Stodghill, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2605 Kentucky Ave, Ste 103, Paducah, KY 42003 Phone: 270-442-9461 Fax: 270-441-0079 | |
Dr. K Brandon Strenge, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2605 Kentucky Ave Ste 102, Paducah, KY 42003 Phone: 270-228-3973 Fax: 270-359-5046 | |
Dr. Jason Gregory Patton, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Clint Hill Blvd, Paducah, KY 42001 Phone: 270-442-9461 Fax: 270-441-0079 | |
Philip G Hunt, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225 Medical Center Dr, Suite 406, Paducah, KY 42003 Phone: 270-441-4868 Fax: 270-441-4869 |